AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART
Authors: Lucia, MB Rutella, S Leone, G Vella, S Cauda, R
Citation: Mb. Lucia et al., HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART, J ACQ IMM D, 27(4), 2001, pp. 321-330
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals
Authors: Veldkamp, AI Weverling, GJ Lange, JMA Montaner, JSG Reiss, P Cooper, DA Vella, S Hall, D Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals, AIDS, 15(9), 2001, pp. 1089-1095
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression
Authors: Grelli, S Di Traglia, L Matteucci, C Lichtner, M Vullo, V Di Sora, F Lauria, F Montella, F Favalli, C Vella, S Macchi, B Mastino, A
Citation: S. Grelli et al., Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression, AIDS, 15(9), 2001, pp. 1178-1181
Access to HIV/AIDS care and treatment in the South of the world
Authors: Kallings, LO Vella, S
Citation: Lo. Kallings et S. Vella, Access to HIV/AIDS care and treatment in the South of the world, AIDS, 15(7), 2001, pp. IAS1-IAS3
Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting
Authors: Miller, V Vandamme, AM Loveday, C Staszewski, S Lundgren, J Youle, M Ait-Khaled, M Boucher, C Brun-Vezinet, F Dedes, N Giaquinto, C Hertogs, K Houyez, F Perrin, L Pillay, D Schmit, JC Schuurman, R Lange, J Banhegyi, D Biondi, G Broekhuizen, A Bush-Donovan, C Camacho, R Carlier, H Clavel, F Clotet, B Clumeck, N Colebunders, R De Clerq, K De Jaegher, JJ De Schrijver, G De Smet, K Hall, W Harrigan, R Hatzakis, A Hellmann, N Hoetelmans, R Holtzer, C Katlama, C Larder, D Loriaux, E McCreedy, B Mulcahy, F Opravil, M Phillips, A Ruiz, N Shulse, E Sonnerborg, A Soriano, V Steel, H Vella, S Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine
Authors: Conway, B Wainberg, MA Hall, D Harris, M Reiss, P Cooper, D Vella, S Curry, R Robinson, P Lange, JMA Montaner, JSG
Citation: B. Conway et al., Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine, AIDS, 15(10), 2001, pp. 1269-1274
Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis
Authors: Matarrese, P Testa, U Cauda, R Vella, S Gambardella, L Malorni, W
Citation: P. Matarrese et al., Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis, BIOCHEM J, 355, 2001, pp. 587-595
Markers of cell death-activation in lymphocytes of vertically HIV-infectedchildren naive to highly active antiretroviral therapy: The role of age
Authors: Vigano, A Pinti, M Nasi, M Moretti, L Balli, F Mussini, C Bricalli, D Sala, N Bugarini, R Vella, S Principi, N Cossarizza, A
Citation: A. Vigano et al., Markers of cell death-activation in lymphocytes of vertically HIV-infectedchildren naive to highly active antiretroviral therapy: The role of age, J ALLERG CL, 108(3), 2001, pp. 439-445
Success hinges on support for treatment
Authors: Hale, P Makgoba, MW Merson, MH Quinn, TC Richman, DD Vella, S Wabwire-Mangen, F Wain-Hobson, S Weiss, RA
Citation: P. Hale et al., Success hinges on support for treatment, NATURE, 412(6844), 2001, pp. 272-272
HIV eradication revisited
Authors: Vella, S Palmisano, L
Citation: S. Vella et L. Palmisano, HIV eradication revisited, EXPERT OP I, 9(2), 2000, pp. 193-197
Randomised, multicentre phase III study of saquinavir plus zidovudine pluszalcitabine in previously untreated or minimally pretreated HIV-infected patients
Authors: Stellbrink, HJ Hawkins, DA Clumeck, N Cooper, DA Myers, R Delfraissy, JF Gill, MJ Ramirez-Ronda, C Vella, S Salgo, M Bragman, K
Citation: Hj. Stellbrink et al., Randomised, multicentre phase III study of saquinavir plus zidovudine pluszalcitabine in previously untreated or minimally pretreated HIV-infected patients, CLIN DRUG I, 20(5), 2000, pp. 295-307
A randomized trial comparing the introduction of ritonavir or indinavir in1251 nucleoside-experienced patients with advanced HIV infection
Authors: Floridia, M Tomino, C Bucciardini, R Ricciardulli, D Fragola, V Pirillo, MF Amici, R Giannini, G Galluzzo, CM Andreotti, M Seeber, AC Ammassari, A Cingolani, A Lazzarin, A Scalise, G Cargnel, A Suter, F Milazzo, F Pastore, G Moroni, M Ciammarughi, R Pini, R Carosi, G D'Amato, C Contu, L Concia, E Bonazzi, L Aiuti, F Vigevani, G Vella, S
Citation: M. Floridia et al., A randomized trial comparing the introduction of ritonavir or indinavir in1251 nucleoside-experienced patients with advanced HIV infection, AIDS RES H, 16(17), 2000, pp. 1809-1820
HIV therapy in the post-eradication era
Authors: Vella, S Palmisano, L
Citation: S. Vella et L. Palmisano, HIV therapy in the post-eradication era, J BIOL REG, 14(1), 2000, pp. 34-37
Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy
Authors: Grelli, S Campagna, S Lichtner, M Ricci, G Vella, S Vullo, V Montella, F Di Fabio, S Favalli, C Mastino, A Macchi, B
Citation: S. Grelli et al., Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy, AIDS, 14(8), 2000, pp. 939-949
Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection
Authors: Cossarizza, A Stent, G Mussini, C Paganelli, R Borghi, V Nuzzo, C Pinti, M Pedrazzi, J Benatti, F Esposito, R Rosok, B Nagata, S Vella, S Franceschi, C De Rienzo, B
Citation: A. Cossarizza et al., Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection, AIDS, 14(4), 2000, pp. 345-355
AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients
Authors: Gartland, M Gerstoft, J Goebel, F Clumeck, N Cooper, DA Gatell, J Gazzard, B Gerstoft, J Goebel, F Lange, J Montaner, J Reiss, P Rozenbaum, W Vella, S Beveridge, A Cooper, DA Duncombe, C Gold, J Haberl, M Clumeck, N Luyts, D Montaner, J Rachlis, A Marina, R Gerstoft, J Wandall, JH Elbrond, B Molina, JM Pialloux, G Rozenbaum, W Beauvais, L Goebel, FD Staszewski, S Bruns, I Hug, M Reiss, P Lange, J Frissen, PHJ van der Ende, ME Bosboom, M Baas, C Milazzo, F Moroni, M Panebianco, R Clotet, B Artigas, JMG Gonzalez-Lahoz, J Leal, M Rodriguez-Lopo, C Gandarias, B Gazzard, B Johnson, M McKinley, S Page, V Watkins, K Sandstrom, E Belsey, E Darbyshire, J Chodakewitz, J Isaacs, R Jonas, L Meibohm, A Coughlan, M Fiddian, P Gartland, M Harrigan, R Larder, B Maguire, M Millard, J Moore, S Patel, K Shortino, D Tisdale, M Vafidis, I Yeo, J
Citation: M. Gartland et al., AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients, AIDS, 14(4), 2000, pp. 367-374
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume
Authors: Vigano, A Vella, S Saresella, M Vanzulli, A Bricalli, D Di Fabio, S Ferrante, P Andreotti, M Pirillo, M Dally, LG Clerici, M Principi, N
Citation: A. Vigano et al., Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume, AIDS, 14(3), 2000, pp. 251-261
Quality of life outcomes of combination zidovudine-didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients
Authors: Bucciardini, R Wu, AW Floridia, M Fragola, V Ricciardulli, D Tomino, C Weimer, LE Pirillo, MF Mirra, M Marzi, M Giannini, G Galluzzo, CM Andreotti, M Massella, M Vella, S
Citation: R. Bucciardini et al., Quality of life outcomes of combination zidovudine-didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients, AIDS, 14(16), 2000, pp. 2567-2574
Highly active antiretroviral therapy including protease inhibitors does not confer a unique CD4 cell benefit
Authors: Reiss, P Vella, S Cooper, D Lange, J Gartland, M Gerstoft, J Goebel, F Larder, B Clumeck, N Gatell, J Gazzard, B Rozenbaum, W Rae, S O'Shaughnessy, MV Robinson, P Harrigan, PR Raboud, J Alexander, CS Maguire, M Montaner, JS
Citation: P. Reiss et al., Highly active antiretroviral therapy including protease inhibitors does not confer a unique CD4 cell benefit, AIDS, 14(10), 2000, pp. 1383-1388
Imagining empire: Company, crown and Bengal in the formation of British imperial ideology, 1757-84
Authors: Vella, S
Citation: S. Vella, Imagining empire: Company, crown and Bengal in the formation of British imperial ideology, 1757-84, PORTUG STUD, 16, 2000, pp. 276-297
Swelling of the third nerve in a child with transient oculomotor paresis: A possible cause of ophthalmoplegic migraine
Authors: Ramelli, GP Vella, S Lovblad, K Remonda, L Vassella, F
Citation: Gp. Ramelli et al., Swelling of the third nerve in a child with transient oculomotor paresis: A possible cause of ophthalmoplegic migraine, NEUROPEDIAT, 31(3), 2000, pp. 145-147
Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment
Authors: Vella, S Galluzzo, MC Giannini, G Pirillo, MF Andreotti, M Tomino, C Fragola, V Bucciardini, R Ricciardulli, D Binelli, A Weimer, LE Floridia, M
Citation: S. Vella et al., Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment, ANTIVIR RES, 47(3), 2000, pp. 189-198
Antiretroviral therapy: state of the HAART
Authors: Vella, S Palmisano, L
Citation: S. Vella et L. Palmisano, Antiretroviral therapy: state of the HAART, ANTIVIR RES, 45(1), 2000, pp. 1-7
Condom use for preventing the spread of HIV/AIDS: an ethical imperative
Authors: Benagiano, G Rezza, G Vella, S
Citation: G. Benagiano et al., Condom use for preventing the spread of HIV/AIDS: an ethical imperative, J ROY S MED, 93(9), 2000, pp. 453-456
SPECT during sleepwalking
Authors: Bassetti, C Vella, S Donati, F Wielepp, P Weder, B
Citation: C. Bassetti et al., SPECT during sleepwalking, LANCET, 356(9228), 2000, pp. 484-485
Risultati: 1-25 | 26-43